港股上市公司医渡科技（02158）今日盘中大涨6.27%，引发市场关注。分析人士认为，这一涨幅与近期发布的医药工业数智化转型政策密切相关。
据悉，4月24日，国家卫健委等七部门联合印发《医药工业数智化转型实施方案(2025-2030年)》。该方案旨在推动医药工业全面数智化转型，提出到2030年，规上医药工业企业基本实现数智化转型全覆盖。方案重点布局了四大专项行动，涵盖数智技术赋能、数智转型推广、数智服务体系建设和数智监管提升等多个方面。
医渡科技作为人工智能医疗领域的领先企业，其业务范围与此次政策高度契合。公司依托"AI医疗大脑"YiduCore，为公共健康、临床与疾病研究、医疗管理、新药研发及健康管理等领域提供AI解决方案。业内专家指出，新政策的实施将为医渡科技带来更多商业机会，有望推动公司在AI制药、智能医疗等领域的业务快速增长。投资者对公司未来发展前景看好，从而推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.